What were Ecolab's Q1 2026 revenue and net income, and where did the company open its first Asian Bioprocessing Applications Lab?

Ecolab reported Q1 2026 revenue of US$4,066.1 million and net income of US$432.6 million, and opened its first Asian Bioprocessing Applications Lab in Dongtan, Korea.

How does Ecolab's new lab in Korea align with its broader growth strategy and what investor concerns remain?

The new lab in Dongtan, Korea supports Ecolab's Life Sciences growth engine and strengthens its footprint in a key biosimilars hub, complementing strong Q1 results and positive full-year sales guidance to positively influence investor perception of the company's growth and efficiency; however, investors should continue monitoring potential margin pressures from tariffs and local supplier costs.

Ecolab (ECL) Reports Strong Q1 Results, Expands Korea Lab

May 8, 2026

Ecolab reported Q1 2026 revenue of US$4.066 billion and net income of US$432.6 million, alongside opening its first Asian Bioprocessing Applications Lab in Dongtan, Korea. This expansion supports the company's Life Sciences growth engine in a key biosimilars hub.

Simply Wall Street

2026-04-28

Ecolab Releases Q1 2026 Financial Results

2026-04-28

Ecolab Q1 2026 Earnings Meet EPS Forecast, Slight Revenue Beat

2026-05-01

Veralto Reports Q1 Earnings Beat, Raises Guidance After Acquisitions

2026-05-07

Ecolab Inc. Reports 1Q 2026 Revenue of $4.07 Billion

2026-05-08

Ecolab (ECL) Reports Strong Q1 Results, Expands Korea Lab